Date / Time | Nov. 18 (Thu), 14:10-15:40 | |
---|---|---|
Channel | Channel 5 | |
Chair(s) |
Hyo Jong Kim (Kyung Hee Univ., Korea) Young Sook Park (Eulji Univ., Korea) |
|
Speakers | 14:10-14:30 | Application of treat-to-target strategy in clinical practice Eun Soo Kim (Kyungpook National Univ., Korea) |
14:30-14:50 | Choosing biologic agents beyond conventional therapy: When and What? Sung Noh Hong (Sungkyunkwan Univ., Korea) | |
14:50-15:10 | Optimal use of therapeutic drug monitoring Adam S. Cheifetz (Harvard Medical School, USA) | |
15:10-15:30 | Prevention of complications from IBD treatments Hyuk Yoon (Seoul National Univ., Korea) | |
15:30-15:40 | Discussion |
Date / Time | Nov. 18 (Thu), 15:55-17:25 | |
---|---|---|
Channel | Channel 5 | |
Chair(s) |
Seung-Jae Myung (Univ. of Ulsan, Korea) Tae Il Kim (Yonsei Univ., Korea) |
|
Speakers | 15:55-16:15 | Using organoids to understand colorectal cancer genetic drivers and guide treatment choice Susan Woods (Univ. of Adelaide, Australia) |
16:15-16:35 | Intestinal organoids as a tool for IBD research Jun Hwan Yoo (CHA Univ., Korea) | |
16:35-16:55 | Applications of patient-derived organoids in the management of colorectal cancer Younjoo Kim (Korea Cancer Center Hosp., Korea) | |
16:55-17:15 | Organoid-based regenerative and precision medicine for IBD Ryuichi Okamoto (Tokyo Medical Dental Univ., Japan) | |
17:15-17:25 | Discussion |